JPMorgan Chase & Co’s Acer Therapeutics Inc. Common Stock (DE) ACER Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-70
| Closed | -$57 | – | 6887 |
|
|
2023
Q3 | $57 | Buy |
70
+22
| +46% | +$18 | ﹤0.01% | 6020 |
|
|
2023
Q2 | $45 | Hold |
48
| – | – | ﹤0.01% | 5842 |
|
|
2023
Q1 | $0 | Hold |
48
| – | – | ﹤0.01% | 6249 |
|
|
2022
Q4 | $0 | Hold |
48
| – | – | ﹤0.01% | 6097 |
|
|
2022
Q3 | $0 | Hold |
48
| – | – | ﹤0.01% | 5955 |
|
|
2022
Q2 | $0 | Hold |
48
| – | – | ﹤0.01% | 6038 |
|
|
2022
Q1 | $0 | Hold |
48
| – | – | ﹤0.01% | 6056 |
|
|
2021
Q4 | $0 | Hold |
48
| – | – | ﹤0.01% | 6010 |
|
|
2021
Q3 | $0 | Hold |
48
| – | – | ﹤0.01% | 5843 |
|
|
2021
Q2 | $0 | Hold |
48
| – | – | ﹤0.01% | 5707 |
|
|
2021
Q1 | $0 | Hold |
48
| – | – | ﹤0.01% | 5445 |
|
|
2020
Q4 | $0 | Hold |
48
| – | – | ﹤0.01% | 5172 |
|
|
2020
Q3 | $0 | Hold |
48
| – | – | ﹤0.01% | 5092 |
|
|
2020
Q2 | $0 | Sell |
48
-16,546
| -100% | – | ﹤0.01% | 5023 |
|
|
2020
Q1 | $33K | Sell |
16,594
-2,115
| -11% | -$4.21K | ﹤0.01% | 4250 |
|
|
2019
Q4 | $75K | Buy |
18,709
+17,019
| +1,007% | +$68.2K | ﹤0.01% | 4115 |
|
|
2019
Q3 | $5K | Sell |
1,690
-19,578
| -92% | -$57.9K | ﹤0.01% | 4641 |
|
|
2019
Q2 | $73K | Buy |
21,268
+5,780
| +37% | +$19.8K | ﹤0.01% | 4123 |
|
|
2019
Q1 | $376K | Buy |
15,488
+6,246
| +68% | +$152K | ﹤0.01% | 3499 |
|
|
2018
Q4 | $186K | Buy |
9,242
+538
| +6% | +$10.8K | ﹤0.01% | 3831 |
|
|
2018
Q3 | $268K | Buy |
8,704
+8,659
| +19,242% | +$267K | ﹤0.01% | 3764 |
|
|
2018
Q2 | $1K | Hold |
45
| – | – | ﹤0.01% | 4730 |
|
|
2018
Q1 | $1K | Sell |
45
-600
| -93% | -$13.3K | ﹤0.01% | 4657 |
|
|
2017
Q4 | $9K | Buy |
+645
| New | +$9K | ﹤0.01% | 4507 |
|